Patents by Inventor Krister Bengt BOKVIST

Krister Bengt BOKVIST has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides and methods for their preparation and use
    Patent number: 8815811
    Abstract: The present invention is in the field of treatment of diabetes and relates to peptides that exhibit activity for both glucose-dependent insulinotropic peptide receptor (GIP-R) and glucagon-like peptide-1 receptor (GLP-1-R) and are selective over glucagon receptor (Gluc-R). Specifically provided are GIP analogs with amino acid substitutions introduced to modulate activity for both GIP-R and GLP-1-R and maintain selectivity over Gluc-R.
    Type: Grant
    Filed: March 23, 2011
    Date of Patent: August 26, 2014
    Assignee: Eli Lilly and Company
    Inventors: Jorge Alsina-Fernandez, Krister Bengt Bokvist, Lili Guo, John Philip Mayer
  • NOVEL PEPTIDES AND METHODS FOR THEIR PREPARATION AND USE
    Publication number: 20110237503
    Abstract: The present invention is in the field of treatment of diabetes and relates to peptides that exhibit activity for both glucose-dependent insulinotropic peptide receptor (GIP-R) and glucagon-like peptide-1 receptor (GLP-1-R) and are selective over glucagon receptor (Gluc-R). Specifically provided are GIP analogs with amino acid substitutions introduced to modulate activity for both GIP-R and GLP-1-R and maintain selectivity over Gluc-R.
    Type: Application
    Filed: March 23, 2011
    Publication date: September 29, 2011
    Applicant: ELI LILLY AND COMPANY
    Inventors: Jorge ALSINA-FERNANDEZ, Krister Bengt BOKVIST, Lili GUO, John Philip MAYER